Carisma Therapeutics Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD from Q1 2023 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Carisma Therapeutics Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and growth rate from Q1 2023 to Q2 2024.
  • Carisma Therapeutics Inc. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending June 30, 2024 was $240K, a 3% increase year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $240K +$7K +3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $240K +$7K +3% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $233K Dec 31, 2023 10-K 2024-04-01
Q3 2023 $233K Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $233K Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $233K Mar 31, 2023 10-Q 2023-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.